Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Hsu Jason, Director. Officer active across 1 company, notably Immix Biopharma, Inc.. Cumulatively, 7 disclosures have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €256k. Activity tracked since 20 December 2021. The latest transaction was filed on 20 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Hsu Jason is Administrateur and Director at Immix Biopharma, Inc. He has 7 filings in total. Across the 7 most recent sampled filings, buys amount to EUR 256082 and sells to EUR 0, and the period runs from 2021-12-20 to 2024-12-26. The modal transaction nature is Acquisition.